Client Feedback
“The HUREL® co-culture can be applied to accurately estimate intrinsic clearance of slowly metabolized drugs and is now utilized as a standard method for in vivo clearance predictions of such compounds in-house.”
– AstraZeneca, Molecular Pharmaceutics
“In our studies evaluating four low-turnover drugs, the HUREL® co-culture model generated a more robust metabolite profile over seven days than was observed following incubation using hepatocyte suspension.”
– Q2 Solutions, Drug Metabolism & Disposition
Videos
Clarinex®: The Hunt for the Unproducible Metabolite
Interspecies Comparison of DMPK Endpoints
Blogs
Improved Prediction of Hepatotoxicity (or DILI) Using HUREL® Hepatic Co-cultures
HUREL® Microliver Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds
![](http://hurel.visikol.com/wp-content/uploads/2021/07/Stock-Photo-1024x564.png)
![](http://hurel.visikol.com/wp-content/uploads/2021/07/Stock-Photo-2-1024x561.png)
Publications
![](https://hurel.visikol.com/wp-content/uploads/2021/07/Publications-1024x444.png)